Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2005-01-31
2005-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis The Tuned waveform reduces defibrillation thresholds (DFTs) when compared to the 50/50% tilt waveform.
Study Methods
* This is an acute, paired-sample, randomized (waveform testing sequence) study
* Patients are implanted with an Food and Drug Administration (FDA) approved St. Jude Medical (SJM) EpicTM+ DR/VR Implantable Cardioverter Defibrillator (or any other standard output ICD after Epic+) and defibrillation lead system.
* All study testing is completed at implant.
* Patients are randomized to begin DFT testing with either the 50/50% tilt or Tuned waveform.
* The HVLIC feature is used to measure the high voltage lead impedance and to program the Tuned and 50/50% tilt waveform pulse widths.
* The DFT is determined by an optimized binary search method that is designed to reduce the overall number of VF inductions to an average of 5.13 while maintaining very high resolution and accuracy.
* Total # of centers - 15 centers
* Sample size - 60 patients
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration
NCT00874445
Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants
NCT00873691
Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study
NCT00500838
POWER (Pulse Width Optimized Waveform Evaluation Trial)
NCT00311181
Testing Objective Methods for Template Matching Ventricular Tachycardia and Pacemapping
NCT01170416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
50/50% Tilt
DFT Testing with a 50/50% tilt
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DFT Testing with a 50/50% tilt
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is able to tolerate DFT testing.
Exclusion Criteria
* Patient is pregnant.
* Patient is less than 18 years old.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
St. Jude Medical
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRD 274
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.